1-2 of 2
Achim Jungbluth
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade

Charlotte E. Ariyan, Mary Sue Brady, Robert H. Siegelbaum, Jian Hu, Danielle M. Bello, Jamie Rand, Charles Fisher, Robert A. Lefkowitz, Kathleen S. Panageas, Melissa Pulitzer, Marissa Vignali, Ryan Emerson, Christopher Tipton, Harlan Robins, Taha Merghoub, Jianda Yuan, Achim Jungbluth, Jorge Blando, Padmanee Sharma, Alexander Y. Rudensky, Jedd D. Wolchok, James P. Allison
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2018) 6 (2): 189–200.
https://doi.org/10.1158/2326-6066.CIR-17-0356
Published: 31 January 2018
View article titled, Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade
Open the PDF for Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade in another window
Includes: Supplementary data
Journal Articles

Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma

Rachel Lubong Sabado, Anna Pavlick, Sacha Gnjatic, Crystal M. Cruz, Isabelita Vengco, Farah Hasan, Meredith Spadaccia, Farbod Darvishian, Luis Chiriboga, Rose Marie Holman, Juliet Escalon, Caroline Muren, Crystal Escano, Ethel Yepes, Dunbar Sharpe, John P. Vasilakos, Linda Rolnitzsky, Judith D. Goldberg, John Mandeli, Sylvia Adams, Achim Jungbluth, Linda Pan, Ralph Venhaus, Patrick A. Ott, Nina Bhardwaj
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (3): 278–287.
https://doi.org/10.1158/2326-6066.CIR-14-0202
Published: 02 March 2015
View article titled, Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma
Open the PDF for Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma in another window